共 64 条
- [1] Starling R.C., The health-care impact of heart failure, Textbook of Cardiovascular Medicine, pp. 2205-2214, (1998)
- [2] Braunwald E., Pathophysiology of heart failure, Heart Disease: A Textbook of Cardiovascular Medicine, pp. 453-483, (1980)
- [3] Bristow M.R., Ginsburg R., Minobe W., Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts, N Engl J Med, 307, pp. 205-211, (1982)
- [4] Bristow M.R., Port J.D., Sandoval A.B., Rasmussen R., Ginsburg R., Feldman A.M., β-Adrenergic receptor pathways in the failing human heart, Heart Failure, pp. 77-90, (1989)
- [5] Movsesian M., Cyclic AMP-mediated signal transduction in heart failure: Molecular pathophysiology and therapeutic implications, J Invest Med, 45, pp. 432-440, (1997)
- [6] De Tombe P.P., Altered contractile function in heart failure, Cardiovasc Res, 37, pp. 367-380, (1998)
- [7] Arai M., Alpert N.R., MacLennan D.H., Parton P., Periasamy P., Alterations in sarcoplasmic reticulum gene expression in human heart failure, Circ Res, 72, pp. 463-469, (1993)
- [8] Rabelink T.J., Stroes E.S.G., Bouter K.P., Morrison P., Endothelin blockers and renal protection: A new strategy to prevent end-organ damage in cardiovascular disease?, Cardiovasc Res, 39, pp. 543-549, (1998)
- [9] Urata H., Healey B., Stewart R.W., Bumpus M., Husain A., Antiotensin II-forming pathways in normal and failing human hearts, Circ Res, 66, pp. 883-990, (1990)
- [10] Tsuchimochi H., Kurimoto F., Ieki K., Koyama H., Fakaku F., Kawana M., Kimata S., Yazaki Y., Atrial natriuretic peptide distribution in fetal and failing adult human hearts, Circulation, 78, pp. 920-927, (1988)